BN Business News
Add your company to Business Communicator →

Prawo i regulacje · 17/04/2026

Royal Emerald Pharmaceuticals Seeks Registration as Controlled Substance Importer

Royal Emerald Pharmaceuticals has submitted an application to the regulatory authorities to be registered as an importer of controlled substances, a move that could impact the pharmaceutical industry.

Source: Federal Register — Justice DepartmentOpen original release →